Suraksha Diagnostic Intrinsic Value
SURAKSHA Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹83.34 | ₹66.67 - ₹100.01 | -70.0% | EPS: ₹6.92, Sector P/E: 12x |
| Book Value Method | asset | ₹210.00 | ₹189.00 - ₹231.00 | -24.4% | Book Value/Share: ₹210.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹256.00 | ₹230.40 - ₹281.60 | -7.8% | Revenue/Share: ₹320.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹555.60 | ₹500.04 - ₹611.16 | +100.0% | EBITDA: ₹100.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹694.50 | ₹555.60 - ₹833.40 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹83.34 | ₹75.01 - ₹91.67 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹83.34 | ₹75.01 - ₹91.67 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹504.00 | ₹453.60 - ₹554.40 | +81.4% | ROE: 17.1%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹180.82 | ₹162.74 - ₹198.90 | -34.9% | EPS: ₹6.92, BVPS: ₹210.00 |
Want to compare with current market value? Check SURAKSHA share price latest .
Valuation Comparison Chart
SURAKSHA Intrinsic Value Analysis
What is the intrinsic value of SURAKSHA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Suraksha Diagnostic (SURAKSHA) is ₹210.00 (median value). With the current market price of ₹277.80, this represents a -24.4% variance from our estimated fair value.
The valuation range spans from ₹83.34 to ₹694.50, indicating ₹83.34 - ₹694.50.
Is SURAKSHA undervalued or overvalued?
Based on our multi-method analysis, Suraksha Diagnostic (SURAKSHA) appears to be trading above calculated value by approximately 24.4%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.58 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.59 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 17.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 31.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.96x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Suraksha Diagnostic
Additional stock information and data for SURAKSHA
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹63 Cr | ₹43 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹61 Cr | ₹44 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹44 Cr | ₹34 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹42 Cr | ₹20 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹24 Cr | ₹10 Cr | Positive Free Cash Flow | 7/10 |